Fisher M, Harbron S, Eggelte H J, Rabin B R
London Biotechnology Limited, Department of Biochemistry and Molecular Biology, University College London, UK.
Enzyme Microb Technol. 1994 Apr;16(4):281-5. doi: 10.1016/0141-0229(94)90167-8.
Nonradioactive immunoassays incorporating an element of amplification in their detection system require the use of components that are highly purified. Flavin adenine dinucleotide-3'-phosphate (FADP) is the primary substrate used in such an amplification assay. For incorporation into a simple, single-pot assay system, the concentration of contaminating flavin adenine dinucleotide (a prosthetic group for the enzyme D-aminoacid oxidase used in the amplification cascade assay) in this primary substrate must be minimized to achieve maximum sensitivity. Production of the substrate to a high degree of purity has been achieved using apo-glucose oxidase to specifically remove contaminating flavin adenine dinucleotide from solution and hydrolysis of a cyclic intermediate as a final production protocol by ribonuclease T2 to give the product in high yield. The use of continuous ultrafiltration reactors at each stage is described and compared to a final production step utilizing immobilized ribonuclease T2. These reactors allow large volumes of material to be handled and assist in the scale-up of these processes. The suitability of each protocol is assessed for the commercial production of FADP.
在检测系统中包含放大元件的非放射性免疫测定需要使用高度纯化的组分。黄素腺嘌呤二核苷酸-3'-磷酸(FADP)是此类放大测定中使用的主要底物。为了纳入一个简单的单罐测定系统,必须将该主要底物中污染性黄素腺嘌呤二核苷酸(在放大级联测定中使用的酶D-氨基酸氧化酶的辅基)的浓度降至最低,以实现最大灵敏度。通过使用脱辅基葡萄糖氧化酶从溶液中特异性去除污染性黄素腺嘌呤二核苷酸,并通过核糖核酸酶T2将环状中间体水解作为最终生产方案,已实现将底物生产至高度纯化,从而高产得到产物。描述了在每个阶段使用连续超滤反应器的情况,并将其与利用固定化核糖核酸酶T2的最终生产步骤进行了比较。这些反应器允许处理大量材料,并有助于扩大这些工艺的规模。评估了每种方案用于FADP商业生产的适用性。